Furthermore, therapeutic intervention using adeno-associated virus (AAV)-mediated knockdown of UCK2/UCKL1 significantly attenuates adverse ventricular remodeling, limits scar expansion, and preserves cardiac function in a murine MI model. This evidence concerns the gene UCKL1 and myocardial infarction.